Advertisement
Canada markets open in 2 hours 50 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7323
    -0.0000 (-0.01%)
     

  • CRUDE OIL

    83.90
    +0.33 (+0.39%)
     

  • Bitcoin CAD

    87,938.59
    +1,243.73 (+1.43%)
     

  • CMC Crypto 200

    1,390.75
    -5.78 (-0.41%)
     

  • GOLD FUTURES

    2,358.30
    +15.80 (+0.67%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,742.50
    +175.00 (+1.00%)
     

  • VOLATILITY

    15.62
    +0.25 (+1.63%)
     

  • FTSE

    8,110.27
    +31.41 (+0.39%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6822
    +0.0001 (+0.01%)
     

Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET

Newsfile Corp.
·1 min read

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will report its financial results for the second quarter ended June 30, 2021, after the market close on Monday, August 30, 2021. The company will host a conference call on Tuesday, August 31, 2021, at 10:30 a.m. ET.

To access the audio broadcast, please dial (866) 652-5200, or via the internet at:
https://services.choruscall.com/mediaframe/webcast.html?webcastid=BaOdjlDg

An archived version of the presentation will be available for 90 days on the "Investors" section of Emerald's website:
https://emeraldhealth.ca/investors/events-and-presentations/

ADVERTISEMENT

About Emerald Health Therapeutics

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products, with an emphasis on science-based innovation and product excellence.

Please visit www.emeraldhealth.ca for more information or contact:

Jenn Hepburn, Chief Financial Officer
(800) 757 3536 Ext. #5

Emerald Investor Relations
(800) 757 3536 Ext. #5
invest@emeraldhealth.ca

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/94337